Treatment | Condition | |
---|---|---|
Absence of nicotine | Presence of nicotine | |
% over control | ||
Control | 100 | 630 ± 97 |
Mecamylamine, (100 μm) | 99 ± 5 | 671 ± 125 |
d-Tubocurarine, (100 μm) | 171 ± 92-a | 675 ± 132 |
HEK 293 cells stably expressing human α4β2 nAChRs were treated with mecamylamine or d-tubocurarine in presence or absence of 1 μm (−)-nicotine, for 168 hr. [3H]Cytisine binding to membranes was performed as described in Materials and Methods.
↵2-a Significantly different from the corresponding controls.
Values are mean ± standard error of three observations.